Bianca Corsi
Family · Hackensack, NJNPI 1427522002
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.9%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Neurelis, Inc. at 50.8% of the total. Reporting peaked in 2022 at $5,053 and has fallen 90.5% since, to $482 in 2025. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $30.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$5K
- SK Life Science, Inc.$2K
- UCB, Inc.$637
- Jazz Pharmaceuticals Inc.$470
- Biocodex, Inc.$468
- Eisai Inc.$319
- plus $968 from 17 others
What the payments were for
- Consulting fees$8029%
- Speaking & faculty fees$3,29336%
- Travel & lodging$2843%
- Food & beverage$4,73152%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 56 | $4,630 |
| SK Life Science, Inc. | 83 | $1,628 |
| UCB, Inc. | 24 | $637 |
| Jazz Pharmaceuticals Inc. | 64 | $470 |
| Biocodex, Inc. | 2 | $468 |
| Eisai Inc. | 22 | $319 |
| Sunovion Pharmaceuticals Inc. | 12 | $222 |
| Zogenix Inc. | 2 | $113 |
| Nobelpharma America, LLC | 3 | $82 |
| Aprecia Pharmaceuticals, LLC | 6 | $79 |
| Livanova USA, Inc. | 3 | $76 |
| Pyros Pharmaceuticals, Inc. | 2 | $72 |
| Bristol Myers Squibb | 4 | $60 |
| Supernus Pharmaceuticals, Inc. | 4 | $55 |
| Upsher-smith Laboratories LLC | 1 | $43 |
| Aquestive Therapeutics, Inc. | 3 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $33 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
| PTC Therapeutics, Inc. | 1 | $15 |
| GSK | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Catalyst Pharmaceuticals, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,121 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.
Other family in Hackensack
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.